Gemfibrozil contraindications

Revision as of 16:10, 13 February 2014 by ShiSheng (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Gemfibrozil
LOPID® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Gemfibrozil
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

1.Hepatic or severe renal dysfunction, including primary biliary cirrhosis. 2.Preexisting gallbladder disease (see WARNINGS). 3.Hypersensitivity to gemfibrozil. 4.Combination therapy of gemfibrozil with repaglinide (see PRECAUTIONS). 5.Combination therapy of gemfibrozil with simvastatin (see WARNINGS and PRECAUTIONS).[1]


References

  1. "DailyMed: Search". Retrieved 13 February 2014.